COMPOSITIONS AND METHODS FOR CONTROLLING ACCUMULATION OF ADIPOSE TISSUE Russian patent published in 2020 - IPC C07K16/26 A61K39/395 

Abstract RU 2711478 C2

FIELD: medicine.

SUBSTANCE: method of treating obesity, type II diabetes or metabolic syndrome using a composition containing a pharmaceutically effective amount of a gastric inhibitory polypeptide (GIP) molecular antagonist, as well as a method for reducing adipose tissue accumulation in the liver, reducing adipose tissue accumulation in the omentum or reducing the accumulation of the subcutaneous fat tissue using the composition containing a pharmaceutically effective amount of the molecular GIP antagonist. Also disclosed is a molecular GIP antagonist. Molecular GIP antagonist comprises a light chain variable domain and a heavy chain variable domain, where the variable light chain domain has 100 % identity with the amino acid sequence SEQ ID NO: 17, SEQ ID NO: 18 or SEQ ID NO: 19, and the heavy chain variable domain has 100 % identity with the amino acid sequence SEQ ID NO: 28, SEQ ID NO: 29 or SEQ ID NO: 30.

EFFECT: group of inventions provides reduced rate of weight gain, low synthesis and accumulation of lipids.

19 cl, 19 dwg, 3 ex

Similar patents RU2711478C2

Title Year Author Number
LY6G6D ANTIBODIES AND METHODS OF USE 2020
  • Lin Weiyu
  • Spiess Christoph
  • Sun Liping
  • Wu Yan
  • Chiu Cecilia P.C.
  • Darbonne Walter Christian
  • Dillon Michael Andrew
RU2818569C1
MOLECULES OF ANTIBODIES TO CD73 AND THEIR APPLICATION WAYS 2018
  • Brok, Ansgar
  • Kremasko, Viviana
  • Sabatos-Pejton, Ketrin, Enn
  • Dranoff, Glenn
  • Prints, Byanka
  • Tomas, Dzherri, M.
  • Cheppel, Skott
  • Lejk, Endryu
  • Paterson, Elison
  • O'Konnor, Rejchel, V.
  • Uorren, Majkl
  • Kholland, Pamela
  • Subramanian, Kulandajan, Kasi
  • Fellskog, Mari-Luiz
  • Byusser, Dirksen
  • Voldegiorgis, Mikias
  • Shu, Vej
  • Venejbl Iii, Dzhon, Delma
  • Gledstoun, Majkl
  • Khill, Dzhonatan
  • Miller, Kristin
RU2791192C2
GIPR ANTIBODY AND ITS GLP-1 FUNCTION PROTEIN AS WELL AS PHARMACEUTICAL COMPOSITION BASED ON IT AND ITS USE 2019
  • Wang, Xiaofeng
  • Zhang, Hua
  • Yao, Chenjiang
  • Zhang, Cheng
  • Jing, Shuqian
RU2800370C2
ANTIBODIES TO CD40 AND METHODS OF USE THEREOF 2016
  • Benatuil Lorentso
  • Ardzhiriadi Mariya A.
  • Makraj Bredford L.
  • Khsiekh Chung-Ming
  • Igan Devid A.
  • Kharlan Dzhon E.
  • Dzhadzh Rassel A.
  • Van Zhuj
  • Kingzberi Dzhillian A.
RU2715597C2
COMPOSITIONS AND METHODS FOR INCREASING BODY WEIGHT AND LEAN MUSCLE MASS USING LEPTIN RECEPTOR ANTAGONISTS, GDF8 AND ACTIVIN A 2019
  • Altarekhos, Dzhudit
  • Gromada, Dzhesper
RU2818832C2
ANTIBODIES AGAINST CD40 AND THEIR USE 2018
  • Yang, Yi
  • Dong, Chunyan
  • Yang, Fang
  • Lu, Chengyuan
  • Shen, Yuelei
  • Ni, Jian
  • Guo, Yanan
  • Chen, Yunyun
  • Xie, Jingshu
RU2796413C2
ANTIBODIES AGAINST PD-L1 AND THEIR OPTIONS 2017
  • Jiang, Weidong
  • Lin, Pei-Hua
  • Tseng, Chi-Ling
RU2770590C2
ANTIBODIES AGAINST OX40 AND THEIR USE 2017
  • Yang, Yi
  • Guo, Yanan
  • Chen, Yunyun
  • Xie, Jingshu
  • Dong, Chunyan
  • Yang, Fang
  • Lu, Chengyuan
  • Cheng, Xiaodong
  • Shen, Yuelei
  • Ni, Jian
RU2783314C2
ANTIBODIES TO ENTPD2, TYPES OF COMBINATION THERAPY AND METHODS FOR USING ANTIBODIES AND TYPES OF COMBINATION THERAPY 2019
  • Didonato, Michael
  • Erkel, Christoph
  • Galkin, Anna
  • Glaser, Scott Martin
  • Hartlepp, Klaus Felix
  • Jia, Yong
  • Kraus, Alexandra
  • Lee, Christian Cho-Hua
  • Rue, Sarah Michelle
  • Shi, Jian
  • Wezler, Xenia Karola
RU2790991C2
METHOD FOR PREVENTION AND TREATMENT OF CANCER METASTASES AND BONE LOSS CAUSED BY CANCER METASTASES 2007
  • Kavanaf Majkl
  • Lju Chehn
RU2470665C2

RU 2 711 478 C2

Authors

Vulf M. Majkl

Bojlan Majkl O.

Dates

2020-01-17Published

2014-12-17Filed